Clinical Evaluation of 18F-AV-1451

What is the purpose of this trial?

Brief Summary:

This study is designed to expand the database of 18F-AV-1451 safety and tau binding as measured by PET imaging and to provide standardized conditions for 18F-AV-1451 use, data collection and analysis to facilitate companion studies including, but not limited to, longitudinal studies of aging, depression, and traumatic brain injury.


http://www.alzheimers.yale.edu




Participation Guidelines

Ages: 55 - 85 years

Gender: Both


Avid Radiopharmaceuticals

Start Date: 10/20/2017

End Date: 07/31/2018

Last Updated: 05/03/2018

Study HIC#: 2000021572

Get Involved

For more information about this study, contact:
Joanna Harris
+1 203-764-8100
joanna.harris@yale.edu

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 1-877-978-8348.

Trial Image